Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New hope for children with eye tumors, cancer

24.06.2003


A deadly form of cancer in children, which starts out as a tumor in the eye, can now be treated successfully by a combination of therapies. This is the conclusion of a study appearing in the June issue of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, the Eye M.D. Association.



Malignant retinal tumors in children, called retinoblastomas, which have spread to the bones, bone marrow and soft tissue can be successfully treated by a combination of high-dose chemotherapy, radiation therapy and transplantation of blood-producing stem cells.

In the study, conducted at St. Jude Children’s Hospital in Memphis, Tennessee, four pediatric patients were treated with intensive chemotherapy – a combination of several very-high-dose anti-cancer drugs – radiation therapy, and the transplantation of the patients’ own blood-producing stem cells. The blood stem cells were harvested after two to four courses of chemotherapy.


In all cases, the bone marrow disease went into complete remission after two courses of chemotherapy, which was followed by radiation and stem-cell therapy. Of the four patients, two survived free of disease longer than six years. In the other two patients, disease recurred in the central nervous system and they did not survive. Disease of the central nervous system continues to be the major obstacle to improved outcomes for patients with metastatic retinoblastomas.

Carlos Rodriguez-Galindo, MD, lead author of the study, said, "Our results show that retinal tumors that metastasize to other areas of the body can be cured. Chemotherapy by itself only results in transient improvement, with all patients dying of disease progression eventually, whereas chemotherapy in combination with radiation and stem-cell therapies can actually save patients’ lives. We believe more than 90 percent of patients can be cured with surgery if the disease is detected early enough, before the disease spreads."

Dr. Rodriguez-Galindo and colleagues are working with Ira J. Dunkel, MD, at Memorial Sloan Kettering Cancer Center in New York and with Eric F. Grabowski, MD, ScD, at Massachusetts General Hospital for Children to develop a national protocol that will apply these principles of therapy to all children with this disease.

Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program (http://seer.cancer.gov), Dr. Rodriguez-Galindo estimates the number of annual retinoblastoma cases in the United States to be between 300 and 350. Of these, approximately 15, or five percent, develop retinal tumors that spread outside of the eye. "However," he said, "in developing countries, close to 40 to 50 percent of retinoblastoma patients develop metastatic disease."

Academy spokesperson William Mieler, MD, said, "This study, along with comparable studies conducted by Drs. Dunkel and Grabowski, provides encouraging evidence that a successful approach to treating this advanced, devastating disease is close at hand. Once the protocol is further established and tested on additional patients, we can hope to see further documentation of effective treatment for patients with advanced metastatic retinoblastoma."


The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons--Eye M.D.s--with more than 27,000 members worldwide. For more information about eye health care, visit the Academy’s partner Web site, the Medem Network, at http://www.medem.com/eyemd. To find an Eye M.D. in your area, visit the Academy’s Web site at http://www.aao.org.

Media Relations | EurekAlert!
Further information:
http://www.medem.com/eyemd
http://www.aao.org

More articles from Health and Medicine:

nachricht Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer
26.03.2020 | Johns Hopkins Medicine

nachricht Too much salt weakens the immune system
26.03.2020 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Junior scientists at the University of Rostock invent a funnel for light

Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.

The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.

Im Focus: Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.

Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....

Im Focus: Artificial solid fog material creates pleasant laser light

An international research team led by Kiel University develops an extremely porous material made of "white graphene" for new laser light applications

With a porosity of 99.99 %, it consists practically only of air, making it one of the lightest materials in the world: Aerobornitride is the name of the...

Im Focus: Cross-technology communication in the Internet of Things significantly simplified

Researchers at Graz University of Technology have developed a framework by which wireless devices with different radio technologies will be able to communicate directly with each other.

Whether networked vehicles that warn of traffic jams in real time, household appliances that can be operated remotely, "wearables" that monitor physical...

Im Focus: Peppered with gold

Research team presents novel transmitter for terahertz waves

Terahertz waves are becoming ever more important in science and technology. They enable us to unravel the properties of future materials, test the quality of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“4th Hybrid Materials and Structures 2020” takes place over the internet

26.03.2020 | Event News

Most significant international Learning Analytics conference will take place – fully online

23.03.2020 | Event News

MOC2020: Fraunhofer IOF organises international micro-optics conference in Jena

03.03.2020 | Event News

 
Latest News

3D printer sensors could make breath tests for diabetes possible

27.03.2020 | Power and Electrical Engineering

TU Bergakademie Freiberg researches virus inhibitors from the sea

27.03.2020 | Life Sciences

The Venus flytrap effect: new study shows progress in immune proteins research

27.03.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>